67 /100
HIGH RISK
Score updated May 30, 2026

LRHC — La Rosa Holdings Corp. Dilution Risk Tracker

Track LRHC dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track LRHC — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
10
📊 Float Risk
100
⚠️ Warrant Exposure
90
🔄Convertible Debt—

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
48%
📜 Warrant Exercise 60%
• Massive warrant overhang: 176% of shares outstanding
• Warrant risk score very high (90/100)
📉 Score Deterioration 50%
• Score rose 35 points recently (worsening)
• Score in HIGH risk zone (67/100)
🔁 Convertible Conversion 15%
• Convertible debt present: 8.7% potential dilution
🔔 Track LRHC — Get forecast alerts →

💹 Market Data

Market Cap$1.38M
Shares Outstanding1.05M
Float13.4K
Cash$3.99M
Debt$10.61M
Short InterestN/A

🏛 Institutional Holdings

2.3% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track LRHC for full holder detail →

📉 Short Interest

Short Interest34.6K
Days to Cover1.0
% of Float258.6%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 14, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2023
3 FORM3 Mar 11, 2026
8-K 8K EVENT Mar 05, 2026
4 INSIDER TRANSACTION Mar 03, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track LRHC Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking LRHC — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: BATL BRN CDIO CDT CNTMD
🔬 More Research for LRHC
📊 LRHC FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 LRHC Signal Convergence & Dark Pool Activity — StonkWhisper 📄 LRHC Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.